Document Classification

Section Type: RESULTS

Text: Nine participants (3 %) receiving abacavir vs. 16 (5 %) receiving nevirapine died [hazard ratio (HR) 0. 55 ; 95 % confidence interval (CI) 0. 24-1. 25 ; P = 0. 15] ; 20 receiving abacavir vs. 32 receiving nevirapine developed new or recurrent WHO 4 events or died (HR = 0. 60 ; 95 % CI 0. 34-1. 05 ; P = 0. 07) and 48 receiving abacavir vs. 68 receiving nevirapine developed new or recurrent WHO 3 or 4 events or died (HR = 0. 67 ; 95 % CI 0. 46-0. 96 ; P = 0. 03).